AstraZeneca’s Mene Pangalos, executive VP of IMED Biotech, has been appointed in two new positions based in Cambridge.
Pangalos will join the board of the Precision Medicine Catapult, the newly established centre in Cambridge designed to shape the future of precision medicine in the UK.
In his role as non-executive director, Pangalos will provide a pharmaceutical industry perspective on how to ensure the UK can remain at the cutting edge of precision medicine.
Additionally, Pangalos has also been appointed an as official fellow of Clare Hall College in the University of Cambridge.
Pangalos said: “I’m delighted to receive these two appointments. Although they are a great personal honour, I believe they are testament to the quality of our science, our pioneering approach to personalised healthcare and our long standing commitment to strengthening the UK life science sector.”